Crossref journal-article
Wiley
Journal of Neuroscience Research (311)
Abstract

AbstractHuman T‐cell leukemia virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurodegenerative disease characterized by selective loss of axons and myelin in the corticospinal tracts. This central axonopathy may originate from the impairment of anterograde axoplasmic transport. Previous work showed tau hyperphosphorylation at T181 in cerebrospinal fluid of HAM/TSP patients. Similar hyperphosphorylation occurs in SH‐SY5Y cells incubated with supernatant from MT‐2 cells (HTLV‐I‐infected lymphocytes secreting viral proteins, including Tax) that produce neurite shortening. Tau phosphorylation at T181 is attributable to glycogen synthase kinase 3‐β (GSK3‐β) and cyclin‐dependent kinase 5 (CDK5) activation. Here we investigate whether neurite retraction in the SH‐SY5Y model associates with concurrent changes in other tau hyperphosphorylable residues. Threonine 181 turned out to be the only tau hyperphosphorylated residue. We also evaluate the role of GSK3‐β and CDK5 in this process by using specific kinase inhibitors (LiCl, TDZD‐8, and roscovitine). Changes in both GSK3‐β active and inactive forms were followed by measuring the regulatory phosphorylable sites (S9 and Y216, inactivating and activating phosphorylation, respectively) together with changes in β‐catenin protein levels. Our results showed that LiCl and TDZD‐8 were unable to prevent MT‐2 supernatant‐mediated neurite retraction and also that neither Y216 nor S9 phosphorylations were changed in GSK3‐β. Thus, GSK3‐β seems not to play a role in T181 hyperphosphorylation. On the other hand, the CDK5 involvement in tau phosphorylation was confirmed by both the increase in its enzymatic activity and the absence of MT‐2 neurite retraction in the presence of roscovitine or CDK5 siRNA transfection. © 2011 Wiley‐Liss, Inc.

Bibliography

Maldonado, H., Ramírez, E., Utreras, E., Pando, M. E., Kettlun, A. M., Chiong, M., Kulkarni, A. B., Collados, L., Puente, J., Cartier, L., & Valenzuela, M. A. (2011). Inhibition of cyclin‐dependent kinase 5 but not of glycogen synthase kinase 3‐β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T‐cell leukemia virus type I‐infected lymphocytes. Journal of Neuroscience Research, 89(9), 1489–1498. Portico.

Authors 11
  1. Horacio Maldonado (first)
  2. Eugenio Ramírez (additional)
  3. Elias Utreras (additional)
  4. María E. Pando (additional)
  5. Ana M. Kettlun (additional)
  6. Mario Chiong (additional)
  7. Ashok B. Kulkarni (additional)
  8. Lucía Collados (additional)
  9. Javier Puente (additional)
  10. Luis Cartier (additional)
  11. María A. Valenzuela (additional)
References 48 Referenced 22
  1. 10.1074/jbc.M409851200
  2. 10.1016/j.biopha.2007.02.005
  3. 10.1152/physrev.00024.2003
  4. 10.1073/pnas.190297597 / Proc Natl Acad Sci U S A / Regulation and localization of tyrosine 216 phosphorylation of glycogen synthase kinase‐3β in cellular and animal models of neuronal degeneration by Bhat RV (2000)
  5. 10.1186/1742-4690-5-76
  6. 10.1093/brain/awl269
  7. 10.1097/00005072-199704000-00009
  8. 10.4067/S0034-98872007000900007
  9. 10.1074/jbc.M206236200
  10. 10.1038/nrn1788
  11. 10.1016/S0166-2236(02)02255-5
  12. 10.1128/jvi.71.9.6982-6989.1997 / J Virol / Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T‐cell lymphotropic virus type 1 Tax by Cowan EP (1997)
  13. 10.1016/j.neuropharm.2008.09.012
  14. 10.3390/ijms10031045
  15. 10.1016/j.molmed.2004.07.001
  16. 10.1146/annurev.neuro.31.061307.090711
  17. 10.1007/s10571-007-9242-1
  18. 10.1046/j.1471-4159.2000.0750991.x
  19. 10.3389/neuro.02.002.2009
  20. 10.1016/j.brainres.2006.04.007
  21. 10.1158/1535-7163.MCT-08-0655
  22. 10.1016/S0301-0082(01)00011-9
  23. 10.1016/j.molmed.2009.01.003
  24. 10.1016/S1937-6448(08)00603-5
  25. 10.1016/j.neuroscience.2005.04.061
  26. 10.1007/s10571-009-9410-6
  27. 10.1074/jbc.M907757199
  28. 10.1074/jbc.M605178200
  29. 10.1111/j.1460-9568.2007.05955.x
  30. 10.1146/annurev.neuro.28.061604.135632
  31. 10.4067/S0716-97602008000300001
  32. 10.1007/s11481-010-9216-9
  33. 10.1074/jbc.M700610200
  34. 10.1373/clinchem.2004.039347
  35. 10.1016/S0140-6736(86)91298-5
  36. 10.1016/j.ymeth.2007.06.012
  37. 10.1016/S0168-1702(02)00276-9
  38. 10.1358/dof.2002.027.05.680587
  39. 10.1074/jbc.274.52.37046
  40. 10.1016/S1388-1981(02)00149-X
  41. 10.1007/PL00012495
  42. 10.1186/1743-8454-5-14
  43. 10.1016/j.mad.2008.12.006
  44. 10.1074/jbc.M211964200
  45. 10.1016/S0014-5793(98)00346-9
  46. 10.1016/j.dnarep.2004.11.006
  47. 10.1038/mt.2008.92
  48. 10.1016/S0896-6273(00)81200-3
Dates
Type When
Created 14 years, 2 months ago (June 10, 2011, 1:29 p.m.)
Deposited 1 year, 10 months ago (Oct. 16, 2023, 2:35 a.m.)
Indexed 1 month, 1 week ago (July 24, 2025, 7:41 a.m.)
Issued 14 years, 2 months ago (June 10, 2011)
Published 14 years, 2 months ago (June 10, 2011)
Published Online 14 years, 2 months ago (June 10, 2011)
Published Print 14 years ago (Sept. 1, 2011)
Funders 0

None

@article{Maldonado_2011, title={Inhibition of cyclin‐dependent kinase 5 but not of glycogen synthase kinase 3‐β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T‐cell leukemia virus type I‐infected lymphocytes}, volume={89}, ISSN={1097-4547}, url={http://dx.doi.org/10.1002/jnr.22678}, DOI={10.1002/jnr.22678}, number={9}, journal={Journal of Neuroscience Research}, publisher={Wiley}, author={Maldonado, Horacio and Ramírez, Eugenio and Utreras, Elias and Pando, María E. and Kettlun, Ana M. and Chiong, Mario and Kulkarni, Ashok B. and Collados, Lucía and Puente, Javier and Cartier, Luis and Valenzuela, María A.}, year={2011}, month=jun, pages={1489–1498} }